Population-Level Temporal Patterns of Distant-Stage Incidence and Cancer-Specific Mortality Across Ten Solid Cancers

BACKGROUND: Distant-stage incidence and cancer-specific mortality describe different aspects of cancer burden. We compared their long-term population trends across 10 solid cancers in the United States. METHODS: Age-adjusted distant-stage incidence from the Surveillance, Epidemiology, and End Results (SEER) Program 17 Registries database (SEER17) and national cancer-specific mortality were analyzed for 2004-2023 using Joinpoint regression. Primary incidence models omitted 2020; mortality models retained 2020. Both endpoints were also analyzed over a common 2004-2019 window. Endpoint direction was defined from the 95% confidence interval for average annual percentage change (AAPC). Relative survival and incidence-based mortality were complementary analyses. RESULTS: Among 5,545,600 incident cancers, 1,060,790 were diagnosed at distant stage. Breast cancer, prostate cancer, and melanoma had increasing distant-stage incidence with declining mortality; lung and colorectal cancers declined in both endpoints; pancreatic, liver and intrahepatic bile duct, and uterine cancers increased in both; and kidney and renal pelvis and stomach cancers had no clear incidence change with declining mortality. All 10 paired patterns were unchanged in the common 2004-2019 window. One- and 3-year distant-stage relative survival increased for all cancers, and all 20 primary survival contrasts remained significant after Benjamini-Hochberg adjustment. CONCLUSIONS: The relation between distant-stage incidence and cancer-specific mortality differed by cancer site and was unchanged in a common pre-pandemic window. Distant-stage incidence is best interpreted alongside, rather than as a substitute for, population mortality.

Authors

Institutions

Publication Details

Journal
JNCI Cancer Spectrum
Published
2026-11-17
DOI
https://doi.org/10.1093/jncics/pkag122
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Population-Level Temporal Patterns of Distant-Stage Incidence and Cancer-Specific Mortality Across Ten Solid Cancers

Cui Chen, Yilin Ye, Lianxin Zhu, Peng Sun et al.
JNCI Cancer Spectrum
Global Cancer Incidence and Screening
article

Population-Level Temporal Patterns of Distant-Stage Incidence and Cancer-Specific Mortality Across Ten Solid Cancers

Cui Chen, Yilin Ye, Lianxin Zhu, Peng Sun, Zhihua Zhu
article en

Abstract

BACKGROUND: Distant-stage incidence and cancer-specific mortality describe different aspects of cancer burden. We compared their long-term population trends across 10 solid cancers in the United States. METHODS: Age-adjusted distant-stage incidence from the Surveillance, Epidemiology, and End Results (SEER) Program 17 Registries database (SEER17) and national cancer-specific mortality were analyzed for 2004-2023 using Joinpoint regression. Primary incidence models omitted 2020; mortality models retained 2020. Both endpoints were also analyzed over a common 2004-2019 window. Endpoint direction was defined from the 95% confidence interval for average annual percentage change (AAPC). Relative survival and incidence-based mortality were complementary analyses. RESULTS: Among 5,545,600 incident cancers, 1,060,790 were diagnosed at distant stage. Breast cancer, prostate cancer, and melanoma had increasing distant-stage incidence with declining mortality; lung and colorectal cancers declined in both endpoints; pancreatic, liver and intrahepatic bile duct, and uterine cancers increased in both; and kidney and renal pelvis and stomach cancers had no clear incidence change with declining mortality. All 10 paired patterns were unchanged in the common 2004-2019 window. One- and 3-year distant-stage relative survival increased for all cancers, and all 20 primary survival contrasts remained significant after Benjamini-Hochberg adjustment. CONCLUSIONS: The relation between distant-stage incidence and cancer-specific mortality differed by cancer site and was unchanged in a common pre-pandemic window. Distant-stage incidence is best interpreted alongside, rather than as a substitute for, population mortality.

JNCI Cancer Spectrum
Sun Yat-sen University (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Sun Yat-sen University Cancer Center (CN), State Key Laboratory of Oncology in South China (CN)
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon